Apimeds Pharmaceuticals US, Inc. (APUS) Revenue

17 Followers

Apimeds Pharmaceuticals US, Inc. Revenue

Apimeds Pharmaceuticals US, Inc. had a revenue of 0.00 in the quarter ending Jun 30, 2026, with ―. This bring the company's revenue in the last twelve months to 0.00, Decreased ―. In the fiscal year ending Dec 31, 2025, Apimeds Pharmaceuticals US, Inc. had annual revenue of 0.00 with ― growth.

Revenue (ttm)

0.00

Revenue Growth

―

P/S Ratio

―

Revenue/Employee

Employees

Market Cap

$3.46M

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	―	―	―
Dec 31, 2024	―	―	―
Dec 31, 2023	―	―	―
Dec 31, 2022	―	―	―
Dec 31, 2021	―	―	―